$255 Million is the total value of HARVEY CAPITAL MANAGEMENT INC's 73 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 26.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AAPL | Sell | APPLE COMPUTER INC | $18,099,000 | +8.0% | 179,649 | -0.4% | 7.10% | +18.3% |
| GILD | Sell | GILEAD SCIENCES | $16,055,000 | +14.7% | 150,825 | -10.6% | 6.30% | +25.7% |
| CELG | Sell | CELGENE CORP | $14,643,000 | +10.0% | 154,500 | -0.3% | 5.74% | +20.6% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $14,266,000 | +9.2% | 576,200 | -0.3% | 5.59% | +19.7% |
| EMC | Sell | EMC CORPORATION | $8,216,000 | +4.9% | 280,800 | -5.5% | 3.22% | +15.0% |
| GE | Sell | GENERAL ELECTRIC CO | $8,071,000 | -20.7% | 315,050 | -18.7% | 3.16% | -13.1% |
| MHRCQ | Sell | MAGNUM HUNTER RES CORP DEL COM | $7,731,000 | -35.3% | 1,388,150 | -4.8% | 3.03% | -29.1% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $3,171,000 | -18.7% | 348,550 | -11.7% | 1.24% | -10.8% |
| PKT | Sell | PROCERA NETWORKS INC | $2,118,000 | -38.7% | 221,100 | -35.4% | 0.83% | -32.8% |
| NVAX | Sell | NOVAVAX INC | $2,063,000 | -12.3% | 494,950 | -2.8% | 0.81% | -3.9% |
| CRZO | Sell | CARRIZO | $1,821,000 | -22.4% | 33,850 | -0.1% | 0.71% | -15.0% |
| HYG | Sell | ISHARES TR IBOXX $ HIGH YIELDiboxx hi yd et | $1,062,000 | -7.4% | 11,550 | -4.1% | 0.42% | +1.5% |
| BKLN | Sell | POWERSHARES ETF TR IIsenior ln port | $1,017,000 | -5.0% | 41,900 | -2.8% | 0.40% | +4.2% |
| CHGG | Sell | CHEGG INC | $248,000 | -88.1% | 39,800 | -86.6% | 0.10% | -87.0% |
| TWTR | Exit | TWITTER INC COM USD0.000005 | $0 | – | -5,100 | -100.0% | -0.07% | – |
| GWPH | Exit | GW PHARMACEUTICALS ADS EA REPRads | $0 | – | -2,000 | -100.0% | -0.08% | – |
| SYT | Exit | SYNGENTA AGspon adr | $0 | – | -3,000 | -100.0% | -0.08% | – |
| CHKP | Exit | CHECK POINT SOFTWARE TECHNOLOGord | $0 | – | -107,310 | -100.0% | -2.57% | – |
| KERX | Exit | KERYX BIOPHARMACEUTICALS | $0 | – | -932,400 | -100.0% | -5.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-10-20
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE COMPUTER INC | 42 | Q3 2023 | 9.0% |
| MICROSOFT CORP | 42 | Q3 2023 | 7.8% |
| COMCAST CL A VTG | 42 | Q3 2023 | 1.7% |
| ISHARES SP 500 INDEX FUND | 42 | Q3 2023 | 1.8% |
| SOCIEDAD QUIMICA MINERA DE CHI | 42 | Q3 2023 | 1.0% |
| BERKSHIRE HATHAWAY INC. CL-A | 42 | Q3 2023 | 0.4% |
| ISHARES SP500/BARRA GROWTH IN | 42 | Q3 2023 | 0.2% |
| BERKSHIRE HATHAWAY INC DEL | 40 | Q3 2023 | 2.8% |
| HONEYWELL INTL INC | 40 | Q3 2023 | 3.2% |
| JOHNSON JOHNSON | 40 | Q3 2023 | 0.5% |
View HARVEY CAPITAL MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-10 |
| 13F-HR | 2024-01-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-04 |
| 13F-HR/A | 2023-05-17 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-27 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-04-22 |
View HARVEY CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.